Schweickert B, Eckmanns T, Bärwolff S, Wischnewski N, Meyer E
Abteilung 3, Fachgebiet Nosokomiale Infektionen, Surveillance von Antibiotikaresistenzen und -verbrauch, Robert Koch-Institut (RKI), Seestr. 10, 13353, Berlin, Deutschland,
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Apr;57(4):399-405. doi: 10.1007/s00103-014-1942-3.
According to the German Protection Against Infection Act (IfSG; section 23 paragraph 4, July 2011), hospitals and clinics for ambulatory surgery are obliged to establish a continuous monitoring of antibiotic consumption in their institute. The introduction of the surveillance of antibiotic consumption aims to contribute to an optimization of antibiotic prescription practices in order to confine the development and spread of resistant pathogens. The local public health authority is entitled to supervise the implementation of legal requirements in the hospital setting. The main aim of this article is to support local public health authorities in coping with this task by providing background information on the surveillance of antibiotic consumption and its role as a key component of antibiotic stewardship programs. Furthermore, criteria suitable for assessing the implementation of a functioning surveillance system are proposed. The possibilities and limitations of the activities of public health authorities in this context are addressed.
根据德国《感染防护法》（IfSG；2011年7月第23条第4款），医院和门诊手术诊所必须对其机构内的抗生素使用情况进行持续监测。引入抗生素使用监测旨在促进抗生素处方行为的优化，以限制耐药病原体的产生和传播。当地公共卫生当局有权监督医院环境中法律要求的执行情况。本文的主要目的是通过提供有关抗生素使用监测的背景信息及其作为抗生素管理计划关键组成部分的作用，支持当地公共卫生当局应对这一任务。此外，还提出了适用于评估有效监测系统实施情况的标准。探讨了公共卫生当局在此背景下活动的可能性和局限性。
